BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27766023)

  • 1. Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam.
    Miura M; Kuwahara A; Tomozawa A; Omae N; Yamamori M; Kadoyama K; Sakaeda T
    Int J Med Sci; 2016; 13(10):749-753. PubMed ID: 27766023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
    Ishibashi T; Harada Y; Takamoto M; Ebihara M; Sugiyama M; Shimazu K; Iwanaga T; Kishikawa R; Makie T; Tsurutani H; Kisanuki K; Mitsuno T; Hirota N; Furuno T; Hiraoka T; Tsumori Y; Matsuura Y; Namba K; Oe T; Inuyama M; Chifu S; Fukunaga H; Ueno Y; Matsukizono K; Genka K
    Jpn J Antibiot; 1998 Dec; 51(12):746-58. PubMed ID: 10077773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
    Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of sulbactam/ampicillin in children].
    Ito S; Mayumi M; Ito M; Mikawa H
    Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of safety between high and low doses of sulbactam/ampicillin: A retrospective observational study in Japanese patients with pneumonia.
    Imanishi K; Nakakura I; Miyabe T; Sako R; Yamauchi K
    J Infect Chemother; 2020 Nov; 26(11):1152-1157. PubMed ID: 32622622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of prophylactic administration of SBT/ABPC for preventing surgical site infection in elderly patients undergoing colorectal surgery.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
    Hepatogastroenterology; 2009; 56(91-92):656-8. PubMed ID: 19621674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and clinical studies of sultamicillin granule in the pediatric field].
    Motohiro T; Sakata Y; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Yamashita F; Takajo N
    Jpn J Antibiot; 1988 Dec; 41(12):1980-2000. PubMed ID: 3249372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin- and ampicillin/sulbactam-resistant Escherichia coli infection in a neonatal intensive care unit in Japan.
    Saida K; Ito Y; Shima Y; Kasuga E; Kusakari M; Miyosawa Y; Baba A
    Pediatr Int; 2016 Jun; 58(6):537-9. PubMed ID: 27322865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
    Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of prophylactic administration of SBT/ABPC for preventing surgical site infection in elderly patients undergoing colorectal surgery.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
    Hepatogastroenterology; 2009; 56(93):992-4. PubMed ID: 19760927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].
    Hattori K; Higashino H; Kobayashi T; Yamamoto C; Nobori U; Nakamura Y; Satou Y; Kurokawa H; Nogi S; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):701-17. PubMed ID: 2746850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics].
    Sato Y; Ishikawa K; Iwata S; Akita H; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):579-93. PubMed ID: 2746843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
    Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
    BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Mar; 42(3):623-38. PubMed ID: 2746846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.